Evidence map›Paper›PMID 25078361›Full record

ReviewJournal of neurovirology2015

JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.

Melissa S Maginnis, Christian D S Nelson, Walter J Atwood

Abstract readReview
In one paragraph

Review in Journal of neurovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. The Role of Glycosylation in Infectious Diseases.Advances in experimental medicine and biology · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Virus recognition of glycan receptors.Current opinion in virology · 2019
    Review
  12. [Progress on pathogenesis of progressive multifocal leukoence-phalopathy].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2018
    Review
  13. Review
  14. Article
  15. Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Melissa S MaginnisDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02912, USA.
Christian D S NelsonDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02912, USA.
Walter J AtwoodDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, 02912, USA. walter_atwood@brown.edu.
John Brown University · USBrown University · US

Funding

The Maine Biomedical Research Network (INBRE)P20GM103423 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI Dustin Lynn Updike · 2012 to 2026
$60.0M
SYNTHETIC CHEMISTRY COREP01NS065719 · NINDS · BROWN UNIVERSITY · PI ATWOOD, WALTER J · 2009 to 2018
$12.3M
Virus-Host Cell Interactions in AIDS-Associated PMLR01NS043097 · NINDS · BROWN UNIVERSITY · PI ATWOOD, WALTER J · 2002 to 2020
$6.1M
Center for Cancer Signaling NetworksP30GM103410 · NIGMS · BROWN UNIVERSITY · PI ATWOOD, WALTER J · 2012 to 2015
$4.3M
Release and trafficking of JC polyomavirus genomes and implications in AIDSF32NS070687 · NINDS · BROWN UNIVERSITY · PI NELSON, CHRISTIAN DOUGLAS STUART · 2010 to 2012
$153k
The Role of Viral Receptors in JCV Reactivation and Progression to PML in AIDSF32NS064870 · NINDS · BROWN UNIVERSITY · PI MAGINNIS, MELISSA · 2009 to 2011
$151k
NIGMS NIH HHS P20 GM103423NIGMS NIH HHS P30 GM103410NIGMS NIH HHS P30GM103410NINDS NIH HHS 5P01NS065719NINDS NIH HHS F32 NS064870NINDS NIH HHS F32NS064870NINDS NIH HHS F32 NS070687NINDS NIH HHS F32NS070687NINDS NIH HHS P01 NS065719NINDS NIH HHS R01 NS043097NINDS NIH HHS R01NS043097
6 · The paper itself

Abstract

The human JC polyomavirus (JCPyV) causes a lifelong persistent infection in the reno-urinary tract in the majority of the adult population worldwide. In healthy individuals, infection is asymptomatic, while in immunocompromised individuals, the virus can spread to the central nervous system and cause a fatal demyelinating disease known as progressive multifocal leukoencephalopathy (PML). There are currently very few treatment options for this rapidly progressing and devastating disease. Understanding the basic biology of JCPyV-host cell interactions is critical for the development of therapeutic strategies to prevent or treat PML. Research in our laboratory has focused on gaining a detailed mechanistic understanding of the initial steps in the JCPyV life cycle in order to define how JCPyV selectively targets cells in the kidney and brain. JCPyV requires sialic acids to attach to host cells and initiate infection, and JCPyV demonstrates specificity for the oligosaccharide lactoseries tetrasaccharide c (LSTc) with an α2,6-linked sialic acid. Following viral attachment, JCPyV entry is facilitated by the 5-hydroxytryptamine (5-HT)2 family of serotonin receptors via clathrin-dependent endocytosis. JCPyV then undergoes retrograde transport to the endoplasmic reticulum (ER) where viral disassembly begins. A novel retrograde transport inhibitor termed Retro-2(cycl) prevents trafficking of JCPyV to the ER and inhibits both initial virus infection and infectious spread in cell culture. Understanding the molecular mechanisms by which JCPyV establishes infection will open up new avenues for the prevention or treatment of virus-induced disease.

Indexed as

Virus AttachmentVirus InternalizationHost-Parasite InteractionsHumansJC VirusLeukoencephalopathy, Progressive MultifocalJC polyomavirusLSTcPMLRetro-2cyclSerotonin receptorSialic acid

Identifiers

PMID25078361
PMCPMC4312552
OpenAlexW2041192078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.